Robotic-assisted lateral lymph node dissection for lower rectal cancer: short-term outcomes in 50 consecutive patients

Kagawa, Hiroyasu; Kinugasa, Yusuke; Shiomi, Akio; Yamaguchi, Takashi; Tsukamoto, Syunsuke; Tomioka, Hiroyuki; Yamakawa, Yushi; Sato, Sumito

doi:10.1007/s00464-014-3760-y

Cited by 64 publications

(44 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The lateral side of the obturator space was exposed to the pelvic wall along the obturator fascia, while the inside of the pelvic wall was dissected to the lateral side of the internal iliac artery. The proximal side was dissected en bloc to the bifurcation of the internal and external iliac arteries (11).…”

Section: Methodsmentioning

confidence: 99%

Index of Estimated Benefit from Lateral Lymph Node Dissection for Middle and Lower Rectal Cancer

Numata

Yamaguchi

Kinugasa

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Index of Estimated Benefit from Lateral Lymph Node Dissection for Middle and Lower Rectal Cancer

Numata

Yamaguchi

Kinugasa

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

“…Locally advanced rectal cancer adherent to adjacent organs in 10%-20%, might be due to direct invasion or inflammation [68] . In locally recurrent rectal cancer, the plane of dissection would be very difficult due to severe fibrosis from previous surgery and adhesions between neo-rectum and adjacent organs [24] .…”

Section: Extended Resectionmentioning

confidence: 99%

Minimal invasive approach for beyond total mesorectal excision/extended resections in rectal cancer

Kumar¹,

Kammar²,

Saklani³

2018

MIS

View full text Add to dashboard Cite

Minimal invasive surgery (MIS) is an accepted modality of treatment for rectal cancer. The indications for MIS have gradually been extended to locally advanced and locally recurrent rectal cancer as a result of technological advances in instrumentation, advances in surgical techniques, increased surgeon experience, and high volume center. However, safety and feasibility of laparoscopic surgery and robotic surgery in beyond total mesorectal excision (b-TME) and extended TME (e-TME) are not well established. This review summarizes the current evidence for MIS approach for b-TME/extended resections in rectal cancer. A systematic search was carried out in PubMed. Studies available in English related to MIS approach in b-TME/e-TME in rectal cancers were identified and evaluated. This review concludes MIS is feasible with good perioperative outcomes in b-TME/e-TME in carefully selected patients. Laparoscopic surgery has considerable learning curve and should be performed by experienced surgical teams. Robotic surgery is feasible and beneficial in complex resection in pelvis. However, evidence for long-term oncological outcomes of MIS in b-TME/e-TME is low and needs to be studied further by randomized controlled trial once enough numbers are possible in institutes with high volume rate.

show abstract

“…For patients selected for LPND, there are several surgical approaches, including open, laparoscopic or robotic techniques. In the literature, there are several reports of successful robotic LPDN and TME resection following nCRT with minimal conversions and complications . This new technology provides an excellent alternative to open or laparoscopic methods, as it not only it provides an excellent field of view with constant retraction, but it also offers good manoeuvrability in the narrowed, confined space of the pelvis.…”

Section: Discussionmentioning

confidence: 99%

Lateral pelvic lymph node dissection for low rectal cancers: A review on current practice

2016

View full text Add to dashboard Cite

The management of rectal cancer with lateral lymph node involvement is distinctly different between Japan and Western countries. In Japan, total mesorectal excision (TME) surgery followed by autonomic nervepreserving lateral pelvic lymph node dissection (LPND) is the standard surgical treatment, whereas in Western countries, patients are subjected to neoadjuvant cheomoradiotherapy followed by TME surgery. The present study aims to explore the current practice and role of LPND in rectal cancer.

show abstract

Robotic-assisted lateral lymph node dissection for lower rectal cancer: short-term outcomes in 50 consecutive patients

Abstract: Robotic-assisted lateral lymph node dissection is a safe, feasible, and useful approach for patients with advanced lower rectal cancer.

Cited by 64 publications

References 26 publications

Index of Estimated Benefit from Lateral Lymph Node Dissection for Middle and Lower Rectal Cancer

Index of Estimated Benefit from Lateral Lymph Node Dissection for Middle and Lower Rectal Cancer

Minimal invasive approach for beyond total mesorectal excision/extended resections in rectal cancer

Lateral pelvic lymph node dissection for low rectal cancers: A review on current practice

Contact Info

Product

Resources

About